Clinical Trial Site

Pamplona 31008

3 studies enrolling now · 4 studies all time

What they study most

ALA Dehydratase Deficient Porphyria (ADP), Acute Hepatic Porphyria, Acute Intermittent Porphyria, Acute Porphyria, Atypical Hemolytic-Uremic Syndrome, Hereditary Coproporphyria (HCP), High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Porphyria, Acute Intermittent, Transthyretin Amyloidosis With Cardiomyopathy, Variegate Porphyria (VP)

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now
• ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP) — Completed